StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 08/20/2013 -- StockRunway.com issues special report on - Monarchy Resources Inc(OTCBB:MONK), STELLAR BIOTECH INC(OTCMKTS:SBOTF), E-Waste Systems Inc(OTCMKTS:EWSI), Advanced Cell Technology, Inc.(OTCBB:ACTC)
Monarchy Resources Inc(OTCBB:MONK) stock is at $0.240, up +4.35 percent from its previous close of $0.23. The stock opened the session at $0.2402 and touched its highest price point at $0.26.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative with -78.76% during previous three months trade. Its recent trading volume was 876,088.00 shares in comparison to its usual trading volume of 72,388.00 shares. Monarchy Resources, Inc., a pre-exploration stage company, focuses on acquiring and developing mineral properties. It owns a 100% interest in an 8 unit claim block named La Carlota Gold Claim containing 97.3 hectares located in the Philippines. The company was founded in 2010 and is based in Manila, the Philippines.
For How Long MONK will Fight for Profitability? Read This Trend Analysis report
STELLAR BIOTECH INC(OTCMKTS:SBOTF) stock is at $1.54, up +8.66 percent from its previous close of $1.4173. Its today’s volume is 373.18K shares in comparison to its usual trading volume of 251,558.00 shares. The stock opened the session at $1.44 and touched its highest price point at $1.55.
SBOTF’s quarterly performance remained green with the percentage of +156.67, while its year to date performance showed that the stock advanced overall +432.87%. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe. The company?s KLH is an immunogenic high-molecular-weight protein, which is used in cancers and therapeutic vaccines for lymphoma, bladder, breast, colon, and other cancers. Its KLH products include pharmaceutical intermediates and research regents, as well as products for vaccine conjugation. The company also provides KLH ELISA test kits used for the quantitative measure of anti-KLH antibodies in serum or plasma samples. Stellar Biotechnologies, Inc. is headquartered in Port Hueneme, California.
For How Long SBOTF’s Gloss will Attract Investors? Find out via this report
E-Waste Systems Inc(OTCMKTS:EWSI) experienced a upsurge of +16.67% to a market valuation of $7.76 per share for previous trading session. After opening the day at $0.06 per share, volume surged to 3.58 million.
During last one month it rose with the percentage of +166.5. Its year to date performance remained progressive with +1066.67%. E-Waste Systems, Inc. provides waste electric and electronic equipment processing services in the United Kingdom and internationally. The company is also involved in the provision of end-to-end solutions in IT asset recovery, e-waste management, and electronics reverse logistics. It offers scrap processing, collection and logistics management, repair and refurbishing, demanufacturing and component harvesting, recycling and materials recovery, data security, reporting and certification, and IT lifecycle support and advisory services. The company was formerly known as Dragon Beverage, Inc. and changed its name to E-Waste Systems, Inc. on May 2011. E-Waste Systems, Inc. was founded in 2008 and is headquartered in Los Altos, California.
Will EWSI Continue To Move Higher? Find Out Here
Advanced Cell Technology, Inc.(OTCBB:ACTC) opened its shares at the price of $0.06 for the day, its closing price was $0.0645 after gaining +0.94% for the day. The company traded with the total volume of 3.63 million shares while its average trading aptitude remained 7.98 million shares. The company has total of 2.56 Billion outstanding shares and its total market capitalization is $165.38 million. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company is conducting various clinical trials for treating macular degeneration, and has a preclinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing. Its intellectual property portfolio includes pluripotent stem cell platforms comprising embryonic stem cell and induced pluripotent stem cell (iPSC) platforms; and other cell therapy research programs, such as opthamology, autoimmune/inflammation, and platelet programs. Advanced Cell Technology, Inc. develops and maintains an intellectual property portfolio, with ownership or licensing of approximately 37 issued patents and approximately 190 patent applications pending in the field of regenerative medicine and stem cell therapy. The company is headquartered in Marlborough, Massachusetts.
Why Should Investors Buy ACTC After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at:http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)